Abstract
Galloway-Mowat syndrome (GAMOS) is an autosomalrecessive disease characterized by the combination of earlyonset nephrotic syndrome (SRNS) and microcephaly with brain anomalies. Here we identified recessive mutations in OSGEP, TP53RK, TPRKB, and LAGE3, genes encoding the four subunits of the KEOPS complex, in 37 individuals from 32 families with GAMOS. CRISPR-Cas9 knockout in zebrafish and mice recapitulated the human phenotype of primary microcephaly and resulted in early lethality. Knockdown of OSGEP, TP53RK, or TPRKB inhibited cell proliferation, which human mutations did not rescue. Furthermore, knockdown of these genes impaired protein translation, caused endoplasmic reticulum stress, activated DNA-damage-response signaling, and ultimately induced apoptosis. Knockdown of OSGEP or TP53RK induced defects in the actin cytoskeleton and decreased the migration rate of human podocytes, an established intermediate phenotype of SRNS. We thus identified four new monogenic causes of GAMOS, describe a link between KEOPS function and human disease, and delineate potential pathogenic mechanisms.
Original language | English (US) |
---|---|
Pages (from-to) | 1529-1538 |
Number of pages | 10 |
Journal | Nature genetics |
Volume | 49 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2017 |
ASJC Scopus subject areas
- Genetics
Fingerprint
Dive into the research topics of 'Mutations in KEOPS-complex genes cause nephritic syndrome with primary microcephaly'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Mutations in KEOPS-complex genes cause nephritic syndrome with primary microcephaly. / Braun, Daniela A.; Rao, Jia; Mollet, Geraldine et al.
In: Nature genetics, Vol. 49, No. 10, 01.10.2017, p. 1529-1538.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Mutations in KEOPS-complex genes cause nephritic syndrome with primary microcephaly
AU - Braun, Daniela A.
AU - Rao, Jia
AU - Mollet, Geraldine
AU - Schapiro, David
AU - Daugeron, Marie Claire
AU - Tan, Weizhen
AU - Gribouval, Olivier
AU - Boyer, Olivia
AU - Revy, Patrick
AU - Jobst-Schwan, Tilman
AU - Schmidt, Johanna Magdalena
AU - Lawson, Jennifer A.
AU - Schanze, Denny
AU - Ashraf, Shazia
AU - Ullmann, Jeremy F.P.
AU - Hoogstraten, Charlotte A.
AU - Boddaert, Nathalie
AU - Collinet, Bruno
AU - Martin, Gaelle
AU - Liger, Dominique
AU - Lovric, Svjetlana
AU - Furlano, Monica
AU - Guerrera, I. Chiara
AU - Sanchez-Ferras, Oraly
AU - Hu, Jennifer F.
AU - Boschat, Anne Claire
AU - Sanquer, Sylvia
AU - Menten, Björn
AU - Vergult, Sarah
AU - De Rocker, Nina
AU - Airik, Merlin
AU - Hermle, Tobias
AU - Shril, Shirlee
AU - Widmeier, Eugen
AU - Yung Gee, Heon
AU - Choi, Won Il
AU - Sadowski, Carolin E.
AU - Pabst, Werner L.
AU - Warejko, Jillian K.
AU - Daga, Ankana
AU - Basta, Tamara
AU - Matejas, Verena
AU - Scharmann, Karin
AU - Kienast, Sandra D.
AU - Behnam, Babak
AU - Beeson, Brendan
AU - Begtrup, Amber
AU - Bruce, Malcolm
AU - Ch'Ng, Gaik Siew
AU - Lin, Shuan Pei
AU - Chang, Jui Hsing
AU - Chen, Chao Huei
AU - Cho, Megan T.
AU - Gaffney, Patrick M.
AU - Gipson, Patrick E.
AU - Hsu, Chyong Hsin
AU - Kari, Jameela A.
AU - Ke, Yu Yuan
AU - Kiraly-Borri, Cathy
AU - Lai, Wai Ming
AU - Lemyre, Emmanuelle
AU - Littlejohn, Rebecca Okashah
AU - Masri, Amira
AU - Moghtaderi, Mastaneh
AU - Nakamura, Kazuyuki
AU - Ozaltin, Fatih
AU - Praet, Marleen
AU - Prasad, Chitra
AU - Prytula, Agnieszka
AU - Roeder, Elizabeth R.
AU - Rump, Patrick
AU - Schnur, Rhonda E.
AU - Shiihara, Takashi
AU - Sinha, Manish D.
AU - Soliman, Neveen A.
AU - Soulami, Kenza
AU - Sweetser, David A.
AU - Tsai, Wen Hui
AU - Tsai, Jeng Daw
AU - Topaloglu, Rezan
AU - Vester, Udo
AU - Viskochil, David H.
AU - Vatanavicharn, Nithiwat
AU - Waxler, Jessica L.
AU - Wierenga, Klaas J.
AU - Wolf, Matthias T.F.
AU - Wong, Sik Nin
AU - Leidel, Sebastian A.
AU - Truglio, Gessica
AU - Dedon, Peter C.
AU - Poduri, Annapurna
AU - Mane, Shrikant
AU - Lifton, Richard P.
AU - Bouchard, Maxime
AU - Kannu, Peter
AU - Chitayat, David
AU - Magen, Daniella
AU - Callewaert, Bert
AU - Van Tilbeurgh, Herman
AU - Zenker, Martin
AU - Antignac, Corinne
AU - Hildebrandt, Friedhelm
N1 - Funding Information: We are grateful to the families and participating individuals for their contribution. We thank the Yale Center for Mendelian Genomics (U54HG006504) and the Care4Rare Canada Consortium for WES. We acknowledge D. Ogino (Yamagata University) for providing the nephrology data for patient B60, H. Sartelet (Département de Pathologie, CHU-Sainte-Justine, Université de Montréal) for providing pathology pictures from the renal biopsy from patient B80, S. Blaser (Hospital for Sick Children, Department of Pediatrics, Division of Neuroradiology, University of Toronto) for providing cranial imaging for patient DC, and S. Ameli (Children’s Medical Center, Tehran University of Medical Sciences) for providing DNA samples of family B50. We thank A. Reis and A. Ekici (Institute of Human Genetics, University of Erlangen-Nuremberg) for supporting the initial GAMOS mapping study conducted by M.Z. We thank D. Libri (Institut Jacques Monod) and M. Saleem (University of Bristol) for reagents. This research was supported by funding from the National Institutes of Health (DK076683) and the Howard Hughes Medical Institute to F.H. F.H. was also supported as the William E. Harmon Professor. W.T. was supported by the ASN Foundation for Kidney Research. B. Behnam was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (Common Fund). N.D.R., S.V. and B. Callewaert were supported as a research fellow, a postdoctoral research fellow, and a senior clinical investigator, respectively, of the Fund for Scientific Research, Flanders. E.W. was supported by the German National Academy of Sciences Leopoldina (LPDS-2015-07). H.Y.G. was supported by the National Research Foundation of Korea, Ministry of Science, ICT and Future planning (2015R1D1A1A01056685) and by the Yonsei University College of Medicine (2015-32-0047). M.T.F.W. was supported by K08-DK095994-05 (NIH) and the Children′s Clinical Research Advisory Committee (CCRAC), Children′s Medical Center, Dallas. M.B. was supported by a Senior Research Scholar Award from Fonds de la Recherche du Québec-Santé (FRQS) and a grant from the Canadian Institutes for Health Research (MOP-84470). O.S.-F. was supported by a KRESCENT Post-Doctoral Fellowship and a McGill Integrated Cancer Research Training (MICRTP) fellowship. T.J.-S. was supported by grant Jo 1324/1-1 from the Deutsche Forschungsgemeinschaft (DFG). T.H. was supported by the German Research Foundation, DFG fellowship (HE 7456/1-1). C.A. was supported by grants from the Agence Nationale de la Recherche (GenPod project ANR-12-BSV1-0033.01), the European Union’s Seventh Framework Programme (FP7/2007-2013/no 305608-EURenOmics), the Fondation Recherche Médicale (DEQ20150331682) and the ‘Investissements d’avenir’ program (ANR-10-IAHU-01). M.F. was supported by grants from the Spanish Society of Nephrology and the Catalan Society of Nephrology. M.D.S. acknowledges financial support from the Department of Health by the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London and King’s College Hospital NHS Foundation Trust. M.Z. was supported by the Deutsche Forschungsgemeinschaft (SFB423). Work in the laboratory of P.C.D. was supported by the Singapore National Research Foundation under the Singapore–MIT Alliance for Research and Technology, the National Institute of Environmental Health Science (ES017010, ES022858, ES002109) and the National Science Foundation (MCB-1412379). F.O. was supported by the European Community’s Seventh Framework Programme (FP7/2007-2013) (EURenOmics; grant 2012-305608). The Nephrogenetics Laboratory at Hacettepe University was established by the Hacettepe University Infrastructure Project (grant 06A101008). P.M.G. was supported by a COBRE Grant (P30 GM110766). C.A.H. was supported by the Dutch Kidney Foundation. S.A.L. was supported by the Max Planck Society and the European Research Council (ERC-2012-StG 310489-tRNAmodi). A. Poduri was supported by the Boston Children’s Hospital Translational Research Program. Publisher Copyright: © 2017 Nature America, Inc., part of Springer Nature. All rights reserved.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Galloway-Mowat syndrome (GAMOS) is an autosomalrecessive disease characterized by the combination of earlyonset nephrotic syndrome (SRNS) and microcephaly with brain anomalies. Here we identified recessive mutations in OSGEP, TP53RK, TPRKB, and LAGE3, genes encoding the four subunits of the KEOPS complex, in 37 individuals from 32 families with GAMOS. CRISPR-Cas9 knockout in zebrafish and mice recapitulated the human phenotype of primary microcephaly and resulted in early lethality. Knockdown of OSGEP, TP53RK, or TPRKB inhibited cell proliferation, which human mutations did not rescue. Furthermore, knockdown of these genes impaired protein translation, caused endoplasmic reticulum stress, activated DNA-damage-response signaling, and ultimately induced apoptosis. Knockdown of OSGEP or TP53RK induced defects in the actin cytoskeleton and decreased the migration rate of human podocytes, an established intermediate phenotype of SRNS. We thus identified four new monogenic causes of GAMOS, describe a link between KEOPS function and human disease, and delineate potential pathogenic mechanisms.
AB - Galloway-Mowat syndrome (GAMOS) is an autosomalrecessive disease characterized by the combination of earlyonset nephrotic syndrome (SRNS) and microcephaly with brain anomalies. Here we identified recessive mutations in OSGEP, TP53RK, TPRKB, and LAGE3, genes encoding the four subunits of the KEOPS complex, in 37 individuals from 32 families with GAMOS. CRISPR-Cas9 knockout in zebrafish and mice recapitulated the human phenotype of primary microcephaly and resulted in early lethality. Knockdown of OSGEP, TP53RK, or TPRKB inhibited cell proliferation, which human mutations did not rescue. Furthermore, knockdown of these genes impaired protein translation, caused endoplasmic reticulum stress, activated DNA-damage-response signaling, and ultimately induced apoptosis. Knockdown of OSGEP or TP53RK induced defects in the actin cytoskeleton and decreased the migration rate of human podocytes, an established intermediate phenotype of SRNS. We thus identified four new monogenic causes of GAMOS, describe a link between KEOPS function and human disease, and delineate potential pathogenic mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=85030166114&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030166114&partnerID=8YFLogxK
U2 - 10.1038/ng.3933
DO - 10.1038/ng.3933
M3 - Article
C2 - 28805828
AN - SCOPUS:85030166114
SN - 1061-4036
VL - 49
SP - 1529
EP - 1538
JO - Nature Genetics
JF - Nature Genetics
IS - 10
ER -